These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 23462208)

  • 21. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases.
    Bernard ME; Wegner RE; Reineman K; Heron DE; Kirkwood J; Burton SA; Mintz AH
    J Cancer Res Ther; 2012; 8(2):215-21. PubMed ID: 22842364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ipilimumab and radiation therapy for melanoma brain metastases.
    Silk AW; Bassetti MF; West BT; Tsien CI; Lao CD
    Cancer Med; 2013 Dec; 2(6):899-906. PubMed ID: 24403263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
    Konstantinou MP; Dutriaux C; Gaudy-Marqueste C; Mortier L; Bedane C; Girard C; Thellier S; Jouary T; Grob JJ; Richard MA; Templier C; Sakji L; Guillot B; Paul C; Meyer N
    Acta Derm Venereol; 2014 Jan; 94(1):45-9. PubMed ID: 23824275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stereotactic radiosurgery to the resection bed for intracranial metastases and risk of leptomeningeal carcinomatosis.
    Ojerholm E; Lee JY; Thawani JP; Miller D; O'Rourke DM; Dorsey JF; Geiger GA; Nagda S; Kolker JD; Lustig RA; Alonso-Basanta M
    J Neurosurg; 2014 Dec; 121 Suppl():75-83. PubMed ID: 25434940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases.
    Chowdhury IH; Ojerholm E; McMillan MT; Miller D; Kolker JD; Kurtz G; Dorsey JF; Nagda SN; Geiger GA; Brem S; O'Rourke DM; Zager EL; Gangadhar T; Schuchter L; Lee JY; Alonso-Basanta M
    Radiat Oncol; 2015 Dec; 10():248. PubMed ID: 26626714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.
    Williams NL; Wuthrick EJ; Kim H; Palmer JD; Garg S; Eldredge-Hindy H; Daskalakis C; Feeney KJ; Mastrangelo MJ; Kim LJ; Sato T; Kendra KL; Olencki T; Liebner DA; Farrell CJ; Evans JJ; Judy KD; Andrews DW; Dicker AP; Werner-Wasik M; Shi W
    Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):22-30. PubMed ID: 28816150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stereotactic radiosurgery for intraventricular brain metastases.
    Farnia B; Voong KR; Brown PD; Allen PK; Guha-Thakurta N; Prabhu SS; Rao G; Wang Q; Zhao Z; Mahajan A
    J Neurosurg; 2014 Dec; 121 Suppl():26-34. PubMed ID: 25434934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival.
    Knisely JP; Yu JB; Flanigan J; Sznol M; Kluger HM; Chiang VL
    J Neurosurg; 2012 Aug; 117(2):227-33. PubMed ID: 22702482
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cyberknife for brain metastases of malignant melanoma and renal cell carcinoma.
    Hara W; Tran P; Li G; Su Z; Puataweepong P; Adler JR; Soltys SG; Chang SD; Gibbs IC
    Neurosurgery; 2009 Feb; 64(2 Suppl):A26-32. PubMed ID: 19165071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases.
    Minniti G; Paolini S; D'Andrea G; Lanzetta G; Cicone F; Confaloni V; Bozzao A; Esposito V; Osti M
    J Neurooncol; 2017 May; 132(3):455-462. PubMed ID: 28260130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gamma knife radiosurgery for malignant melanoma brain metastases.
    Seung SK; Sneed PK; McDermott MW; Shu HK; Leong SP; Chang S; Petti PL; Smith V; Verhey LJ; Wara WM; Phillips TL; Larson DA
    Cancer J Sci Am; 1998; 4(2):103-9. PubMed ID: 9532412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical outcomes of melanoma brain metastases treated with stereotactic radiosurgery and anti-PD-1 therapy, anti-CTLA-4 therapy, BRAF/MEK inhibitors, BRAF inhibitor, or conventional chemotherapy.
    Ahmed KA; Abuodeh YA; Echevarria MI; Arrington JA; Stallworth DG; Hogue C; Naghavi AO; Kim S; Kim Y; Patel BG; Sarangkasiri S; Johnstone PA; Sahebjam S; Khushalani NI; Forsyth PA; Harrison LB; Yu M; Etame AB; Caudell JJ
    Ann Oncol; 2016 Dec; 27(12):2288-2294. PubMed ID: 27637745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiation necrosis with stereotactic radiosurgery combined with CTLA-4 blockade and PD-1 inhibition for treatment of intracranial disease in metastatic melanoma.
    Fang P; Jiang W; Allen P; Glitza I; Guha N; Hwu P; Ghia A; Phan J; Mahajan A; Tawbi H; Li J
    J Neurooncol; 2017 Jul; 133(3):595-602. PubMed ID: 28500560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial.
    Margolin K; Ernstoff MS; Hamid O; Lawrence D; McDermott D; Puzanov I; Wolchok JD; Clark JI; Sznol M; Logan TF; Richards J; Michener T; Balogh A; Heller KN; Hodi FS
    Lancet Oncol; 2012 May; 13(5):459-65. PubMed ID: 22456429
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Melanoma brain metastases treated with stereotactic radiosurgery and concurrent pembrolizumab display marked regression; efficacy and safety of combined treatment.
    Anderson ES; Postow MA; Wolchok JD; Young RJ; Ballangrud Å; Chan TA; Yamada Y; Beal K
    J Immunother Cancer; 2017 Oct; 5(1):76. PubMed ID: 29037215
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome.
    Kotecha R; Miller JA; Venur VA; Mohammadi AM; Chao ST; Suh JH; Barnett GH; Murphy ES; Funchain P; Yu JS; Vogelbaum MA; Angelov L; Ahluwalia MS
    J Neurosurg; 2018 Jul; 129(1):50-59. PubMed ID: 28799876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CTLA-4 blockade with ipilimumab induces significant clinical benefit in a female with melanoma metastases to the CNS.
    Hodi FS; Oble DA; Drappatz J; Velazquez EF; Ramaiya N; Ramakrishna N; Day AL; Kruse A; Mac Rae S; Hoos A; Mihm M
    Nat Clin Pract Oncol; 2008 Sep; 5(9):557-61. PubMed ID: 18665147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Timing and type of immune checkpoint therapy affect the early radiographic response of melanoma brain metastases to stereotactic radiosurgery.
    Qian JM; Yu JB; Kluger HM; Chiang VL
    Cancer; 2016 Oct; 122(19):3051-8. PubMed ID: 27285122
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Concurrent Radiosurgery and Immune Checkpoint Inhibition: Improving Regional Intracranial Control for Patients With Metastatic Melanoma.
    Murphy B; Walker J; Bassale S; Monaco D; Jaboin J; Ciporen J; Taylor M; Dai Kubicky C
    Am J Clin Oncol; 2019 Mar; 42(3):253-257. PubMed ID: 30557166
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stereotactic radiosurgery combined with anti-PD1 for the management of melanoma brain metastases: A retrospective study of safety and efficacy.
    Carron R; Gaudy-Marqueste C; Amatore F; Padovani L; Malissen N; Balossier A; Loundou A; Bonnet N; Muracciole X; Régis JM; Grob JJ
    Eur J Cancer; 2020 Aug; 135():52-61. PubMed ID: 32535348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.